Up very late reading a Harvard case study on how Target ALS, a disease where little progress had been made in 100 years, brought vision ("everyone lives"), funding, and broke down silos to supercharge innovation. Let's do the same for kidney health. case.hks.harvard.edu/dan-doctorof...

The Sunday plenary xenotransplantation session at #KidneyWk is worth watching on YouTube. In addition to so many exciting developments, glad to hear the patient voice is helping drive innovation forward.

“Everyone Lives” - Target ALS documentary worth watching. Three operating principles: • Impatient Optimism (urgency + belief) • Deliberate Disruption (break what’s broken) • Radical Collaboration (dissolve silos) Time to get deliberately impatient about kidney health.

Great #KidneyWk. Exciting developments in pharma and transplantation. But here’s what keeps me up: dialysis innovation has barely moved. It’s the third leg of the stool, and we’re pretending a two-legged stool is stable. Time to get serious about breakthrough dialysis technology.

Surprised when basic science kidney researchers at #KidneyWk tell me they rarely talk with kidney patients. We need to flip this. Show researchers the real lives their work impacts. Motivation isn’t abstract — it’s human. Let’s build those connections systematically.

Excellent #KidneyWk presentation by @glombandit.bsky.social on why kidney biopsies still matter in membranous nephropathy. Plus the integration of rigorous clinical thinking with her kidney artwork. Well done.

Seeing @daniel-batlle.bsky.social and @jwaitz.bsky.social at #KidneyWk — always a reminder that nephrology’s strength is in its people. Leaders who engage, contribute, and elevate the conversation.

#KidneyWk: Join us for a policy/advocacy/community health meetup. If you are interested in these topics, this conversation is for you. Today at 6pm. Open to all.

Kidney Week. Here to connect with the people building nephrology’s unrecognizable future. DMs open. #KidneyWk

For our conversations at #KidneyWk... What if we built nephrology from scratch today? Not tweaked it. Not optimized the current system. Not made dialysis 3% better or transplant waitlists slightly shorter. Started over. Clean sheet of paper. 2025 tools. 2025 thinking.

Interested in policy, advocacy, and population health to benefit 850 million people with kidney disease? Stop by the meet up at #KidneyWk.

🙏to Northwestern Medicine Transplant for showing the inspiring transplant documentary ABUNDANT. Nephrology and transplant programs - consider doing the same. abundantmovie.com

Going to Kidney Week and interested in policy, advocacy, and population health? Join us at the meet up at #KidneyWK!

Kidney disease isn't keeping me down. Explored Toronto running a half marathon.

Happy Diwali to everyone who is celebrating!

Interested in policy, advocacy, and population health? Join us at the meet up at #KidneyWK!

Hello #NephJC. Mostly lurking tonight. I do keep a low carb, moderate protein diet. I like what it does for my weight and blood sugar levels.

Hi #NephJC. If you or anyone you know are going to Kidney Week and have an interest in policy, advocacy, or population health, consider dropping by the meet-up below.

Loved watching @kidneyrebel.bsky.social grand rounds at @nu-nephrology.bsky.social!! Thank you for the PKD mega blocks shout out #nephjc (1), happy to be at the right overlap in my Venn diagram (2), and trying to build toward a medical specialty in a hill (3) www.youtube.com/watch?v=RlTC...

At the Chicago Marathon cheering on my daughter as she raises money for PKD research. @pkdfoundation.bsky.social support.pkdcure.org/fundraiser/6...

My renal grand rounds talk at @nu-nephrology.bsky.social An honor I will remember for a long time. youtu.be/RlTC0g4oNPM?...

Thank you to Orhi Esarte Palomero, PhD. for a tour of his advanced electron microscope lab at @nu-nephrology.bsky.social that is doing pioneering work in visualizing the molecular basis of kidney and other diseases. news.feinberg.northwestern.edu/2025/08/12/n...

Exciting developments in Nephrology! Let's keep accelerating the speed of innovation. www.livescience.com/health/scien...

Just donated to the @nephjc.bsky.social pledge drive. Let's show our support and keep this going! www.nephjc.com/news/2025/9/...

Thank you to @nu-nephrology.bsky.social for hosting me at renal grand rounds today. Such a thrill to talk about creating an unrecognizable future for nephrology.

Super excited to give renal grand rounds at @nu-nephrology.bsky.social. If you are interested in watching, DM me and I'll send you the Zoom link.

Excited to give Renal Grand Rounds at @nu-nephrology.bsky.social The place where my kidney advocacy all started.

First Triathlon done.

Very happy that Kidney News published my call for a kidney care revolution. Thank you to @asnpublications and everyone who has guided me along the way.

Super excited to have my patient voice research commentary published in the Clinical Journal of the American Society of Nephrology. Thank you for the opportunity, CJASN! journals.lww.com/cjasn/fullte...

I had a great time talking with the @ASNKidney TREKS participants today. I am always inspired by the students, post docs, and residents' passion for Nephrology.

Super excited to be meeting with the @ASNKidney TREKS participants tomorrow and do my part to build tomorrow's Nephrology workforce. Always a highly motivated group of medical and graduate students.

My daughter in medical school evangelizing Nephrology as she moves apartments.

Not a good week of press for the US Organ Procurement Organizations. We in the kidney community must ensure these organizations are above reproach. www.thefp.com/p/nonprofits...

Exciting, clear, and concise summary by @nephrosparks.bsky.social and Dr. Arash Ataei of RGLS4326, a potential breakthrough in ADPKD research. www.kidneynews.org/view/journal...

As someone with kidney disease, I am very supportive of increasing the donor pool. But we must be very careful with the lives of donors. www.nytimes.com/2025/07/20/u...

What would dialysis look like if every dialysis provider had to spend time attached to a chair, fatigued, and on fluid restriction?

Innovation in nephrology is often closely tied to technological advances. Cellophane led to the dialysis machine. Teflon led to AVF access. Advanced computing to donation chains. Let's keep our eyes open for technology advances that can be leveraged for the kidney.

Glad to see journal articles and a Kidney Week early session on Nephrology and GenAI. There must be some gold in all that data kidney patients generate.

a world without the need for dialysis is looking possible (rather than 'better dialysis' or better transplant') with GLP1RAs in particular - but also flozins, and all the new ways that are coming online for IgAN It's a glorious time to be in nephrology and offer meaningful treatments

After years of stagnation with dialysis technology, let's ask ourselves what are the big risks, the moon shots, the crazy steps we can take to create a whole new dialysis technology...and with that, a whole new nephrology.

Rough NIH Senate Appropriations Committee hearing. Let's keep the pressure on. If you are impacted by NIH funding - which is basically all of us - contact your elected officials, speak up, and speak out.

Let's support the courageous scientists who wrote the Bethesda Declaration!

Add your name in support of the NIH scientists speaking out on what is happening at the NIH. I did. www.standupforscience.net/bethesda-dec...

It is our duty to support everyone at the NIH who has risked their career to sign this letter. A profile in courage for medical research. apnews.com/article/nih-...

Thankful to the leadership at Northwestern University as it fights to keep its NIH funded researchers going. www.chicagotribune.com/2025/06/07/w...

Great to see so many people at the NKF Illinois Walk who are working hard every day for kidney patients including @nu-nephrology.bsky.social.

Nephrology people...this is no time to stay silent. "...some of the biggest changes will be felt at the NIH, where the budget document lists 2026 funding at $27.5 billion, down from nearly $48.5 billion in 2025." amp.cnn.com/cnn/2025/05/...

Tolvaptan for PKD went generic. The insurance company is making me go generic, but I'll always appreciate Otsuka Pharmaceuticals - you funded the drug trials, you stuck with it when times got tough, and you made sure I had access to the medication for almost 7 yrs. @ $10 /month max. 🙏

We need more articles like this one, discussing the impact of federal NIH research cuts on communities are far from Washington DC. This is no time to be silent. kffhealthnews.org/news/article...